Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2025-03-01 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 related to disclosure of events. The content is about notifying the schedule of investor/analyst meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report attachments. The document is short (2084 characters) and serves as an announcement of an event rather than a financial report or detailed presentation. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories like Investor Presentation or Earnings Release.
2025-03-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and explicitly states that no unpublished price sensitive information will be shared. The content is an announcement of upcoming investor meetings and does not contain any financial data, report, or detailed presentation. The document length is short (2150 characters), and it serves as an intimation rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Innova Captab Limited to stock exchanges (BSE and NSE) regarding a regulatory compliance matter. It informs about a penalty imposed by the Registrar of Companies (ROC) on a material subsidiary for default in filing financial statements for the financial year 2018-19. The document references SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which mandates disclosure of material events. The document is dated February 14, 2025, and includes an annexure detailing the penalty and related information. The content is an intimation or announcement of a regulatory event rather than a full financial report or audit report. It does not contain financial statements or detailed financial analysis but is a compliance disclosure under SEBI regulations. The document length is 4116 characters, which is relatively short and consistent with a regulatory announcement. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on February 6, 2025, discussing the financial and operational performance for the third quarter and nine months ended December 31, 2024. It includes management commentary, financial highlights, business updates, and a Q&A session with analysts. The presence of detailed financial data, management discussion, and Q&A indicates this is a full earnings call transcript rather than a brief earnings release or presentation. The document is about 15,000 characters long, which is consistent with a full transcript. Therefore, the appropriate classification is Call Transcript (CT).
2025-02-13 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is a Monitoring Agency Report for the quarter ended December 31, 2024, related to the utilization of IPO proceeds by Innova Captab Limited. It is issued pursuant to SEBI regulations and prepared by CRISIL Ratings Limited, the Monitoring Agency. The report details the use of funds raised through the IPO, confirming compliance with the stated objectives and providing financial data on the utilization of proceeds. This type of report is a regulatory compliance document specifically monitoring the use of capital raised, not a full annual or quarterly financial report, earnings release, or management discussion. It is a specialized report related to capital utilization and regulatory monitoring, which fits best under the category of Capital/Financing Update (CAP). The document is substantive (15,000 characters) and contains detailed financial and compliance information, not merely an announcement or certification, so it is not RPA or RNS. Therefore, the appropriate classification is CAP with high confidence.
2025-02-11 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a submission to stock exchanges (BSE and NSE) regarding the approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. It includes an extract of a newspaper advertisement published on February 6, 2025, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is primarily an announcement of the financial results approval and publication, not the full financial report itself. The document length is 15,000 characters, but the text indicates it is a notice and extract of advertisement, not the full financial statements or detailed analysis. Therefore, it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results and related compliance, not the full Interim/Quarterly Report (IR) or Annual Report (10-K).
2025-02-06 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.